Related Articles
PSMA and RLT: The VISION and TheraP Trials “Presentation” – Michael Morris
At the 2024 UCSF-UCLA PSMA Conference, Michael Morris reviews the VISION and TheraP trials, underscoring their significance in advancing PSMA PET imaging and radioligand therapy…
April 2024 – Volume 9 – Issue 2 : PAIN Reports
The open home of global research and emerging pain science, PAIN Reports is an official publication of IASP. View free articles at and learn more…
ASN asks Congress to increase funding for the US transplant system
The American Society of Nephrology has called on Congress to increase funding for the U.S. transplant system by $8 million in fiscal year 2025, according…
We need to stop infantilising young adults
Over-protectiveness may be well meant but it stifles the dynamism that this country needs
Genomic discordances and heterogeneous mutational burden, PD-L1 expression and immune infiltrates of non-small cell lung cancer metastasis
Aims To investigate the genomic discordances and heterogeneous mutational burden, PD-L1 expression and immune cell (IC) infiltrates of non-small cell lung cancer (NSCLC) metastasis. Methods…
Timothy Wilt, MD, MPH: What Age Should Patients Get Screened for Colorectal Cancer?
Wilt discusses ACP guidelines regarding what age to begin colorectal cancer screening and the benefits versus harms of screening at 45 compared to 50 years…
Discover Your Roadmap to Improved GI Care: AGA’s 2024 Postgraduate Course – DDW News
Can’t come make it to D.C.? Attend the AGA Postgraduate Course online and acquire state-of-the-art approaches to support your patients.
Patient advocates shred Becerra’s copay accumulator comments during House hearing
Lawmakers pressed Department of Health and Human Services Secretary Xavier Becerra over the Biden administration’s stance toward Medicare Advantage, rural health and more during budgetary…
Kids can’t wait any longer for social media safety
Millions of children are coming of age in an unrestricted and unprotected digital universe. They need guardrails that can keep them safe.
Researchers Question Credibility of Subgroup Analyses in Cancer Trials – Renal and Urology News
Subgroup analyses in cancer trials may not be credible, and their results should be interpreted with caution, according to researchers.